Functional Stability Measured by Changes in 6-Minute Walking Distance in Patients Treated With Tafamidis vs Placebo: Post Hoc Analysis From ATTR-ACT
Witteles R, Hanna M, Grogan M, Marino V, Wang R, Garcia Pavia P
ACC 2026
- 美国心脏病学会（ACC）第75届年度科学会议暨博览会
| 罕见病 | 转甲状腺素蛋白淀粉样变性 | 维万心
Relative Importance of Markers of Progression in Patients With Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Post Hoc Analysis
Garcia Pavia P, Hanna M, Marino V, Wang R, Grogan M, Witteles R
ACC 2026
- 美国心脏病学会（ACC）第75届年度科学会议暨博览会
| 罕见病 | 转甲状腺素蛋白淀粉样变性 | 维万心
Temporal Identification of Early Comorbidities for Enhanced Detection of ATTRwt-CM: A Medicare Analysis
Grodin JL, Willet A, Chung H, Silver M, Sienko D, Dai F, Pankratova C, Shah SJ
ACC 2026
- 美国心脏病学会（ACC）第75届年度科学会议暨博览会
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Describing the diagnostic journeys of transthyretin amyloid cardiomyopathy patients in the United States: a real-world survey
Willet A, Chung H, Ines M, Branquinho P, Wright J, Garratt-Wheeldon J, Smethers K, Braid A, Chandrasekar S, Baker C
ACC 2026
- 美国心脏病学会（ACC）第75届年度科学会议暨博览会
| 罕见病 | 转甲状腺素蛋白淀粉样变性
